PTX — Prescient Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Prescient Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12.3	21.9	14.5	6.93	9.03
Net Total Accounts Receivable
Net Total Receivables	1.72	2.58	3.92	4.91	3.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets	14.2	24.7	18.7	12.9	14
Net Property, Plant And Equipment	0.005	0.003	0.002	0.007	0.219
Net Intangible Assets
Other Long Term Assets
Total Assets	17.6	28.1	20.4	14.6	16.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.809	2.03	2.32	3.16	1.96
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.856	2.03	2.33	3.17	2.08
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	16.8	26.1	18.1	11.4	14.2
Total Liabilities & Shareholders' Equity	17.6	28.1	20.4	14.6	16.3
Total Common Shares Outstanding